资讯
Stifel Virtual Immunology and Inflammation Forum September 16, 2025 12:30 PM EDTCompany ParticipantsMartin Babler - President, ...
Queen Mary is celebrating our postdocs and the contributions they make to research, impact, and culture during National ...
Analyst/Investor event showcases opportunities for KO-2806 (darlifarnib) in combination with PI3Ka inhibitors, KRAS inhibitors and antiangiogenic tyrosine kinase inhibitors (TKIs) Preliminary clinical ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果